Susan E. Manley

8.1k citations

51 papers · 5.8k indexed · 4 hit papers · h-index 21

Impact in

Endocrinology, Diabetes and Metabolism top 0.2%
- Diabetes, Cardiovascular Risks, and Lipoproteins
- Diabetes Management and Research
- Diabetes Treatment and Management
Nephrology top 0.5%
- Chronic Kidney Disease and Diabetes

Papers in

Endocrinology, Diabetes and Metabolism 32
- Diabetes Management and Research 20
- Diabetes, Cardiovascular Risks, and Lipoproteins 19
- Hyperglycemia and glycemic control in critically ill and hospitalized patients 11
- Diabetes Treatment and Management 8
Nephrology 3

Co-authors: Rury R. Holman Irene Stratton H. A. W. Neil Amanda Adler Richard Stevens R. C. Turner David R. Matthews C A Cull
Journals: Diabetologia (8 papers)Diabetic Medicine (7 papers)Clinical Chemistry (4 papers)Renal Failure (3 papers)Diabetes Research and Clinical Practice (3 papers)
Partner nations: United Kingdom United States Ireland

In The Last Decade

Susan E. Manley

51 papers receiving 5.5k citations

Hit Papers

align trajectories log scale

Development and progression of nephropathy in type 2 diabetes: The United Kingdom Prospective Diabetes Study (UKPDS 64) 2003 · 1.3k citations

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if any of the following hold:

it has ≥500 total citations;
it reaches ≥1.5× the top-1% citation threshold for papers in the same subfield and year (the threshold is the minimum needed to enter the top 1%, not the average within it);
it reaches the top citation threshold in at least one of its specific research topics.

2003 Kidney International
2001 Diabetologia
1998 BMJ
1997 The Lancet

Peers

Countries citing papers authored by Susan E. Manley

Since Specialization

Citations

This map shows the geographic impact of Susan E. Manley's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Susan E. Manley with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Susan E. Manley more than expected).

Fields of papers citing papers by Susan E. Manley

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Susan E. Manley. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Susan E. Manley. The network helps show where Susan E. Manley may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Susan E. Manley, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Susan E. Manley Line = papers co-authored together Susan E. Manley links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	use of HbA1c for new diagnosis of diabetes in those with hyperglycaemia on admission to or attendance at hospital urgently requires research British Journal of Diabetes ·Susan E. Manley, Andreas Karwath, John A. Williams, Peter Nightingale, Jonathan Webber, Rajeev Raghavan, Yeup Heo, Craig Webster, Paul Merkley, Irene Stratton, Georgios V. Gkoutos, Graham Roberts, Samiul Mostafa, Sandip Ghosh	2022	1
2	The effect of glibenclamide on insulin secretion at normal glucose concentrations Diabetologia ·Miller-Antonio, Yuta Ihara, Susan E. Manley, Rury R. Holman, J Lévy	2014	12
3	Comparison of IFCC-calibrated HbA1c from laboratory and point of care testing systems Diabetes Research and Clinical Practice ·Susan E. Manley, Sheida Mohebali, Paul Merkley, Karmen Selić, Stephen D. Luzio, Gareth Dunseath, Peter Nightingale, Irene Stratton, Robert Cramb, Ken Sikaris, Stephen Gough, Jonathan Webber	2014	12
4	PEPtalk: postexposure prophylaxis against varicella in children with cancer Archives of Disease in Childhood ·Jessica Bate, Julia Chisholm, Paul T. Heath, Judith Breuer, Roderick Skinner, Susan E. Manley, Soonie R Patel, Keith Wheatley, Mary Ramsay, Pamela Kearns, Sophie Hambleton	2011	12
5	How should HbA(1c) be incorporated into the diagnostic pathway for diabetes mellitus Diabetologia ·Susan E. Manley, Peter Nightingale, Ken Sikaris, Irene Stratton, Robert Cramb, Edwin Shillington	2010	1
6	Diffuse central nervous system protoplasmic astrocytoma Pediatric Blood & Cancer ·Susan E. Manley, Daniel Crooks, Welliton da Silva Belém, Neil Buxton, Richard Appleton, Andrew Riordan, Gavin Cleary, Barry Pizer	2010	2
7	Estimated average glucose derived from HbA_1c (eAG): report from European Association for the Study of Diabetes (EASD), Amsterdam 2007 Diabetic Medicine ·Susan E. Manley	2008	8
8	Validation of an algorithm combining haemoglobin A_1c and fasting plasma glucose for diagnosis of diabetes mellitus in UK and Australian populations Diabetic Medicine ·Susan E. Manley, Ken Sikaris, Z. Lu, Peter Nightingale, Irene Stratton, Paul Merkley, V. Baskar, Stephen Gough, Janet M. Smith	2008	29
9	Calibration of HbA_1c and its measurement in the presence of variant haemoglobins: report on questionnaire to manufacturers Annals of Clinical Biochemistry International Journal of Laboratory Medicine ·Susan E. Manley, Paul Merkley, Janet M. Smith	2006	11
10	Introduction of IFCC reference method for calibration of HbA_1c: implications for clinical care Diabetic Medicine ·Susan E. Manley, W. Garry John, Sally M. Marshall	2004	17
11	Parallel changes of proinsulin and islet amyloid polypeptide in glucose intolerance Diabetes Research and Clinical Practice ·Yarden Hagian, B. Barrow, Susan E. Manley, J Lévy, Anne Clark, R. C. Turner	2000	9
12	Effects of three months' diet after diagnosis of Type 2 diabetes on plasma lipids and lipoproteins (UKPDS 45) Diabetic Medicine ·(unknown), Susan E. Manley, Irene Stratton, C A Cull, Valeria Frighi, Arcos Dominguez, D.R. Matthews, Rury R. Holman, R. C. Turner, H. A. W. Neil	2000	47
13	Plasma lipids and hypoglycaemic therapies over 6 years in Type 2 diabetic patients in the UKPDS Diabetologia ·C A Cull, А.Ю. Елизаров, Valeria Frighi, Susan E. Manley, Rury R. Holman, R. C. Turner, 隆史久下	1999	1
14	Urinary Biomarkers: Roles in Risk Assessment to Environmental and Occupational Nephrotoxins: Monitoring of Effects and Evaluation of Mechanisms of Toxicity Renal Failure ·Richard Price, Richard P. Wedeen, Maureen Y. Lichtveld, Jeffrey A. Lybarger, George A. Porter, Lüder Fels, Hilmar Stolte, Robert Safirstein, Patricia W. Mueller, Susan E. Manley, P. H. Whiting, R. Ariel Gómez, Meiqi Chu	1999	2
15	Characterization of the MODY3 phenotype. Early-onset diabetes caused by an insulin secretion defect. Journal of Clinical Investigation ·Markku Lehto, (unknown), Melanie M. Mahtani, Elisabeth Widén, Carol Forsblom, Leena Sarelin, Peter G Kremsner, Bo Isomaa, Mikko Lehtovirta, A. Materazzi, Timo Kanninen, Marju Orho, Susan E. Manley, R. C. Turner, Thomas Brettin, Andrew Kirby, Jeffrey Thomas, Geoffrey M. Duyk, Eric S. Lander, Marja‐Riitta Taskinen, Leif Groop	1997	168
16	UKPDS 25: autoantibodies to islet-cell cytoplasm and glutamic acid decarboxylase for prediction of insulin requirement in type 2 diabetes The Lancet ·Robert C. Turner, Irene Stratton, V. Horton, Susan E. Manley, Paul Zimmet, Lauren Grace Mackey, Marion Shattock, Gian Franco Bottazzo, Rury R. Holman Hit paper breakdown →	1997	572
17	The fasting hyperglycaemia study: I. Subject identification and recruitment for a non—insulin-dependent diabetes prevention trial Metabolism ·M S Hammersley, Laurent Meyer, R J Morris, Susan E. Manley, R. C. Turner, Rury R. Holman	1997	13
18	Post-prandial amylin concentrations are increased by sulphonylurea, but unchanged by basal insulin, in NIDDM Diabetologia ·Jonathan Rachman, Dennis Sen, J Lévy, B. Barrow, Susan E. Manley, R R Holman, R. C. Turner	1996	2
19	UK PROSPECTIVE DIABETES STUDY (UKPDS) .11. BIOCHEMICAL RISK-FACTORS IN TYPE-2 DIABETIC-PATIENTS AT DIAGNOSIS COMPARED WITH AGE-MATCHED NORMAL SUBJECTS Diabetic Medicine ·Susan E. Manley, Laurent Meyer, А.Ю. Елизаров, I.S. Ross, R. C. Turner, R R Holman	1994	76
20	UK PROSPECTIVE DIABETES STUDY (UKPDS) .10. URINARY ALBUMIN EXCRETION OVER 3 YEARS IN DIET-TREATED TYPE-2, (NON-INSULIN-DEPENDENT) DIABETIC-PATIENTS, AND ASSOCIATION WITH HYPERTENSION, HYPERGLYCEMIA AND HYPERTRIGLYCERIDEMIA Diabetologia ·C A Cull, Susan E. Manley, Valeria Frighi, Rury R. Holman, R. C. Turner	1993	69

About Susan E. Manley

Susan E. Manley is a scholar working on Endocrinology, Diabetes and Metabolism, Nephrology, Surgery, Statistics, Probability and Uncertainty and Genetics, having authored 51 papers that have together received 5.8k indexed citations. Recurring topics across this work include Diabetes Management and Research (20 papers), Diabetes, Cardiovascular Risks, and Lipoproteins (19 papers), Hyperglycemia and glycemic control in critically ill and hospitalized patients (11 papers), Pancreatic function and diabetes (10 papers), Metabolism, Diabetes, and Cancer (9 papers), Diabetes Treatment and Management (8 papers), Diabetes and associated disorders (7 papers) and Pharmacology and Obesity Treatment (4 papers). The work is most often cited by research in Endocrinology, Diabetes and Metabolism (3.5k citations), Nephrology (915 citations), Ophthalmology (654 citations), Cardiology and Cardiovascular Medicine (1.1k citations) and Genetics (992 citations). Susan E. Manley has collaborated with scholars based in United Kingdom, United States and Ireland. Frequent co-authors include Rury R. Holman, Irene Stratton, H. A. W. Neil, Amanda Adler, Richard Stevens, R. C. Turner, David R. Matthews, C A Cull, Helen Millns and Rudy Bilous. Their work appears in journals such as Diabetologia, Diabetic Medicine, Clinical Chemistry, Renal Failure and Diabetes Research and Clinical Practice.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact